ACE inhibition modifies exercise-induced pro-angiogenic and mitochondrial gene transcript expression

Scand J Med Sci Sports. 2016 Oct;26(10):1180-7. doi: 10.1111/sms.12572. Epub 2015 Sep 26.

Abstract

Skeletal muscle responds to endurance exercise with an improvement of biochemical pathways that support substrate supply and oxygen-dependent metabolism. This is reflected by enhanced expression of associated factors after exercise and is specifically modulated by tissue perfusion and oxygenation. We hypothesized that transcript expression of pro-angiogenic factors (VEGF, tenascin-C, Angpt1, Angpt1R) and oxygen metabolism (COX4I1, COX4I2, HIF-1α) in human muscle after an endurance stimulus depends on vasoconstriction, and would be modulated through angiotensin-converting enzyme inhibition by intake of lisinopril. Fourteen non-specifically trained, male Caucasians subjects, carried out a single bout of standardized one-legged bicycle exercise. Seven of the participants consumed lisinopril in the 3 days before exercise. Biopsies were collected pre- and 3 h post-exercise from the m. vastus lateralis. COX4I1 (P = 0.03), COX4I2 (P = 0.04) mRNA and HIF-1α (P = 0.05) mRNA and protein levels (P = 0.01) showed an exercise-induced increase in the group not consuming the ACE inhibitor. Conversely, there was a specific exercise-induced increase in VEGF transcript (P = 0.04) and protein levels (P = 0.03) and a trend for increased tenascin-c transcript levels (P = 0.09) for subjects consuming lisinopril. The observations indicate that exercise-induced expression of transcripts involved in angiogenesis and mitochondrial energy metabolism are to some extent regulated via a hypoxia-related ACE-dependent mechanism.

Keywords: Muscle; angiotensin; exercise; gene; hypertension; hypoxia; lisinopril; perfusion.

MeSH terms

  • Adult
  • Angiopoietin-1 / genetics
  • Angiopoietin-1 / metabolism
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Electron Transport Complex IV / genetics
  • Electron Transport Complex IV / metabolism
  • Energy Metabolism / drug effects
  • Exercise / physiology*
  • Exercise Test
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / genetics
  • Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
  • Lisinopril / pharmacology*
  • Male
  • Mitochondria / genetics*
  • Mitochondria / metabolism
  • Neovascularization, Physiologic / drug effects
  • Quadriceps Muscle / physiology
  • RNA / metabolism*
  • RNA, Mitochondrial
  • Tenascin / genetics
  • Tenascin / metabolism
  • Transcription, Genetic / drug effects*
  • Vascular Endothelial Growth Factor A / genetics
  • Vascular Endothelial Growth Factor A / metabolism
  • Young Adult

Substances

  • ANGPT1 protein, human
  • Angiopoietin-1
  • Angiotensin-Converting Enzyme Inhibitors
  • HIF1A protein, human
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • RNA, Mitochondrial
  • Tenascin
  • Vascular Endothelial Growth Factor A
  • RNA
  • Lisinopril
  • COX4I1 protein, human
  • COX4I2 protein, human
  • Electron Transport Complex IV

Associated data

  • GENBANK/GR218993